This review highlights new pathophysiological mechanisms of peripartum cardiomyopathy, including oxidative stress and angiogenic signaling imbalances, which offer promising therapeutic targets such as bromocriptine.
No takes yet. Share an insight, caveat, or question.
May support bromocriptine in PPCM; hypothesis-generating and leaves open confirmation in prospective trials.
Bachelier‐Walenta et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: